Jianguo Sun Selected Research

Phlebitis

8/2016	Integrated scientific data bases review on asulacrine and associated toxicity.
4/2016	Identification and characterization of in vivo metabolites of asulacrine using advanced mass spectrophotometry technique in combination with improved data mining strategy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianguo Sun Research Topics

Disease

43	Neoplasms (Cancer) 05/2024 - 12/2007
26	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 12/2015
14	Lung Neoplasms (Lung Cancer) 01/2024 - 12/2007
9	Neoplasm Metastasis (Metastasis) 01/2024 - 09/2011
8	Glaucoma 03/2023 - 09/2016
7	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2012
7	Hepatocellular Carcinoma (Hepatoma) 12/2017 - 04/2011
5	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 09/2011
4	Brain Ischemia (Cerebral Ischemia) 01/2024 - 03/2014
4	Inflammation (Inflammations) 05/2023 - 09/2021
3	Stroke (Strokes) 01/2024 - 05/2023
3	Ischemic Stroke 01/2024 - 12/2022
3	Disease Progression 04/2023 - 04/2016
3	Type 2 Diabetes Mellitus (MODY) 01/2023 - 12/2015
3	Carcinoma (Carcinomatosis) 07/2017 - 01/2012
2	Adenocarcinoma of Lung 01/2024 - 02/2022
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 12/2023
2	Wounds and Injuries (Trauma) 05/2023 - 01/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2023 - 01/2016
2	Ocular Hypertension (Glaucoma, Suspect) 01/2023 - 12/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2019
2	Uveitis 01/2023 - 01/2022
2	COVID-19 09/2021 - 08/2021
2	Pain (Aches) 01/2021 - 01/2021
2	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2021
2	Blindness (Hysterical Blindness) 10/2017 - 05/2015
2	Cicatrix (Scar) 08/2017 - 01/2017
2	Phlebitis 08/2016 - 04/2016
2	Leukemia 08/2016 - 07/2013
2	Lymphatic Metastasis 03/2016 - 04/2013
2	Reperfusion Injury 01/2016 - 03/2014
2	Osteoporosis 10/2013 - 01/2013
2	Glioma (Gliomas) 10/2013 - 10/2012
1	Stomach Neoplasms (Stomach Cancer) 02/2024
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2024

Drug/Important Bio-Agent (IBA)

11	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2018
10	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2013
9	Tyrosine Kinase InhibitorsIBA 02/2022 - 05/2016
7	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2012
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2023 - 09/2011
6	ErbB Receptors (EGF Receptor)IBA 02/2022 - 05/2016
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2022 - 05/2016
4	BerberineIBA 01/2024 - 01/2023
4	MicroRNAs (MicroRNA)IBA 05/2023 - 07/2013
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2021 - 09/2016
4	Gefitinib (Iressa)FDA Link 12/2019 - 05/2016
3	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2018
3	Neuroprotective AgentsIBA 01/2024 - 04/2012
3	Ophthalmic Solutions (Eye Drops)IBA 03/2023 - 12/2022
3	Silicon Dioxide (Silica)FDA LinkGeneric 01/2023 - 12/2018
3	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 01/2023 - 03/2017
3	proxalutamideIBA 12/2021 - 10/2020
3	Arachidonic Acid (Vitamin F)IBA 01/2021 - 10/2013
3	Messenger RNA (mRNA)IBA 01/2021 - 03/2017
3	Radiation-Sensitizing AgentsIBA 01/2018 - 10/2012
3	asulacrineIBA 12/2016 - 04/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012 - 12/2007
2	LigandsIBA 01/2024 - 01/2023
2	Oxygen (Dioxygen)IBA 01/2024 - 05/2023
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 05/2023
2	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2023
2	Interleukin-6 (Interleukin 6)IBA 12/2023 - 05/2023
2	hydroxide ionIBA 09/2023 - 03/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2023 - 03/2016
2	Hematoxylin (Haematoxylon)IBA 05/2023 - 01/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 05/2023 - 01/2017
2	Silicone Elastomers (SE 30)IBA 01/2023 - 12/2022
2	Retinaldehyde (Retinal)IBA 01/2023 - 01/2022
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2022 - 12/2018
2	EndostatinsIBA 03/2022 - 02/2012
2	PlatinumIBA 02/2022 - 04/2016
2	Nerve Growth Factors (Neurotrophins)IBA 01/2022 - 12/2017
2	Androgen Receptors (Androgen Receptor)IBA 12/2021 - 10/2020
2	pembrolizumabIBA 01/2021 - 01/2019
2	Circulating Tumor DNAIBA 05/2020 - 01/2019
2	B7-H1 AntigenIBA 01/2020 - 01/2018
2	SolutionsIBA 12/2019 - 08/2017
2	Metformin (Glucophage)FDA LinkGeneric 12/2019 - 12/2015
2	Peptides (Polypeptides)IBA 01/2019 - 09/2007
2	Cadherins (E-Cadherin)IBA 01/2019 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 12/2017 - 12/2007
2	Amsacrine (AMSA)IBA 12/2016 - 08/2016
2	Plant Preparations (Preparation, Plant)IBA 01/2016 - 08/2009
2	AcidsIBA 01/2016 - 01/2007
2	CpG ODN107IBA 10/2013 - 10/2012
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2012 - 12/2010
1	6-methyladenineIBA 01/2024
1	N-methyladenosineIBA 01/2024
1	MethyltransferasesIBA 01/2024
1	Small Cytoplasmic RNAIBA 01/2024
1	VaccinesIBA 01/2024
1	Cancer VaccinesIBA 01/2024
1	Butyric Acid (Butanoic Acid)IBA 12/2023

Therapy/Procedure

18	Therapeutics 01/2024 - 01/2012
15	Radiotherapy 05/2022 - 10/2012
10	Drug Therapy (Chemotherapy) 12/2023 - 12/2007
8	Immunotherapy 05/2024 - 05/2019
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2023 - 03/2014
2	Filtering Surgery 08/2017 - 01/2017
1	Adjuvant Radiotherapy 02/2024